News | March 09, 2024
Jagsonpal Pharmaceuticals launches QueeZy-ER
The product combines proven efficacy of Doxylamine succinate 20 mg and Pyridoxine hydrochloride 20 mg in an Extended Release formulation
The product combines proven efficacy of Doxylamine succinate 20 mg and Pyridoxine hydrochloride 20 mg in an Extended Release formulation
The company has reported total income of Rs. 62.15 crores during the period ended June 30, 2023
Operating EBITDA grew by 82.7 % to Rs. 14.4 crore, EBITDA margin at 23.9%, and Profit After Tax (PAT) grew by 47.1% to Rs. 7.8 crore
The company has reported total income of Rs. 61.64 crores during the period ended September 30, 2022.
Manish led SeQuent since 2014 and played a major role in transforming the company
Suvinys Developers will supply dydrogesterone to Jagsonpal Pharma as per the terms and conditions mentioned in the agreement.
Subscribe To Our Newsletter & Stay Updated
_256_275.jpg)